Treace Medical Concepts Prices Upsized Initial Public Offering

Treace Medical Lapiplasty

Treace Medical Concepts priced its upsized initial public offering of an aggregated 11,250,000 shares of its common stock at a public offering price of USD $17.00 per share. The gross proceeds from the offering to Treace are expected to be approximately $106.3 million.

Treace has developed the Lapiplasty 3D Bunion Correction System,...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us